The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

More than a year after its promised deadline to investors, drugmaker puts alarming results in federal government's "virtual ...

In a large-scale trial, modRNA was significantly better at preventing confirmed flu cases than a typical seasonal flu shot.

Pfizer Canada says it has placed temporary limits on orders of one of its COVID shots at community pharmacies, found outside ...

Pharmacies are seeing high demand for Pfizer COVID vaccine, yet many have not seen a shipment from the company in weeks, ...

An mRNA influenza vaccine bests an inactivated quadrivalent flu vaccine against two different strains in phase 3 study.

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported in the ...

FRIDAY, Nov. 21, 2025 (HealthDay News) — Pfizer’s mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 ...

Vaccine experts said the memo was irresponsible and omits key details about how officials arrived at the conclusion.

The top vaccine chief at the Food and Drug Administration sent out a memo saying the FDA will seek a stricter review and ...

Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. | Pfizer has ...